Source link : https://www.newshealth.biz/health-news/another-injectable-toxoid-vaccine-flops-for-c-diff/
A toxoid vaccine candidate against Clostridioides difficile failed to reduce the incidence of infection in at-risk adults ages 50 and older, according to results of the phase III CLOVER trial. Of trial participants who received three shots of the vaccine (PF-06425090) included in the analysis, the vaccine efficacy (VE) for reducing the incidence of C. […]
Author : News Health
Publish date : 2024-08-28 18:09:42
Copyright for syndicated content belongs to the linked Source.
Categories